Bonus share: Just single issue with record date this week: Pharma firm's free shares with 68% returns since IPO; ratio

Concord Biotech has announced a 1:1 bonus share issue, meaning shareholders will receive one additional share for every one they currently own. The record date for this distribution is November 4, which requires investors to hold the stock in their demat accounts by the previous trading day, November 3, to qualify. This move is a way for the company to reward its existing shareholders and increase the liquidity of its stock in the market.

For investors, this bonus issue can be a positive signal, as it effectively increases the number of shares held without any additional cost. The company has already delivered strong returns to its early investors, with shares gaining 68% since its IPO. While the stock has seen some volatility recently, such corporate actions often boost market sentiment and can attract new buyers looking for value.

Moving forward, investors should focus on the company's future earnings reports and its ability to maintain growth. The bonus issue is a one-time event, so the long-term performance of the stock will depend on the company's operational success. Keep an eye on the volume of trading in the days following the record date, as increased activity often follows such announcements.